Hormone and Metabolic Research

LinksSchließen

Referenz

Attia S, Eickhoff J, Wilding G, McNeel D, Blank J, Ahuja H, Jumonville A, Eastman M, Shevrin D, Glode M.
Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer.

Clin Cancer Res 2008;
14: 2437-2443

Bibliographische Angaben herunterladen

Aufrufen in: